Lung Cancers Completed Phase 1 Trials for Carboplatin (DB00958)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00025480Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment
NCT01486602Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment
NCT02033551A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid TumorsTreatment
NCT00533585BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT00107250AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)Treatment
NCT00032032Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerTreatment
NCT00033410Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerTreatment
NCT00016315Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung CancerTreatment
NCT00005806Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT01069328Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)Basic Science